OBJECTIVES: To review the characteristics and performance of research ethics committees in Spain in the evaluation of multicentre clinical trial drug protocols. DESIGN: A prospective study of 100 applications. SETTING: Forty-one committees reviewing clinical trial protocols, involving 50 hospitals in 25 cities. MAIN MEASURES: Protocol-related features, characteristics of research ethics committees and evaluation dynamics. RESULTS: The 100 applications involved 15 protocols (of which 12 were multinational) with 12 drugs. Committees met monthly (except one). They had a mean number of 12 members, requested a mean of six complete dossiers and nine additional copies of the protocol with a mean deadline of 14 days before the meeting. All applications were approved except three (two of the three were open-label long-term safety trials rejected by the same committee), which were approved by the other committees involved. The mean time from submission to approval was 64 days. The mean time from submission to arrival of the approval document at our offices was 85 days. Twenty-five committees raised queries for 38 of the 97 finally approved applications. Impact of evaluation fee, number of members, queries raised and experience of committees on timings were not statistically significant. CONCLUSION: Obtaining ethical approval is time-consuming. There is much diversity in the research ethics committees' performance. A remarkable delay (> 20 days) exists between the decision and the arrival of the written approval, suggesting administrative or organisational problems.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Other content recommended for you
- Multicentre trials review process by research ethics committees in Spain: where do they stand before implementing the new European regulation?
- The evaluation of complex clinical trial protocols: resources available to research ethics committees and the use of clinical trial registries—a case study
- Incorporating ethical principles into clinical research protocols: a tool for protocol writers and ethics committees
- Guidance for reporting outcomes in clinical trials: scoping review protocol
- Importance and role of independent data monitoring committees (IDMCs) in oncology clinical trials
- Research ethics committees in Europe: implementing the directive, respecting diversity
- Legislative regulation and ethical governance of medical research in different European Union countries
- Ethics committees for biomedical research in some African emerging countries: which establishment for which independence? A comparison with the USA and Canada
- Implementation of the EU clinical trial regulation transforms the ethics committee systems and endangers ethical standards
- What are local issues? The problem of the local review of research